NEW YORK (GenomeWeb) – The National Institutes of Health today announced it awarded $29 million in fiscal 2014 to expand the Rare Diseases Clinical Research Network (RDCRN).

As a result of the funding, researchers at 22 consortia will collaborate with representatives of 98 patient advocacy groups to further clinical research and investigate new treatments for patients diagnosed with rare diseases, which affect about 25 million Americans.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.